IonQ’s stock dipped about 1% on Wednesday, closing at $55.26, even as the company rolled out a new quantum research facility and wrapped up a major shareholder vote. The stock had traded as low as $52.94 during the session, with volume coming in at around 23.8 million — slightly below its recent average.
The new facility is a 22,000-square-foot lab in Boulder, Colorado, focused on R&D and chip testing for IonQ’s trapped-ion quantum hardware. The site is expected to house a quantum computer by Q3 2025, giving the company a concrete near-term milestone as it looks to scale production and improve chip quality.
Colorado state and local officials backed the project with tax credits tied to job creation. IonQ says the lab will add dozens of high-paying roles, including quantum scientists, systems engineers, and operations managers. Governor Jared Polis called Colorado “a quantum hub,” while Boulder Mayor Aaron Brockett highlighted the city’s push to attract next-generation tech firms.
CEO Niccolo de Masi said in a press release that IonQ is applying its technology to real-world problems, including drug discovery, power grid management, and agricultural output.
Alongside the lab news, IonQ received shareholder approval for its $1.8 billion acquisition of SkyWater Technology. The deal adds domestic chip fabrication capacity to IonQ’s supply chain and is expected to strengthen its position in defense and government contracts — two markets that have become increasingly important for quantum hardware companies.
The acquisition has been viewed as a vertical integration move, giving IonQ more control over the production of the ion trap chips that sit at the core of its quantum systems.
IonQ reported Q1 2026 revenue of $64.67 million, well above the analyst estimate of $49.75 million. That’s a 754.7% increase from the same period last year. The growth reflected both contract wins and the company’s expanding backlog.
However, the company posted an EPS loss of -$0.34, missing the consensus estimate of -$0.26 by $0.08. Analysts currently expect a full-year loss of -$1.95 per share. IonQ’s 50-day moving average sits at $37.42 and its 200-day at $43.48, meaning the stock has outrun both levels by a wide margin.
JPMorgan raised its price target on IONQ from $42 to $50 on May 7, assigning a neutral rating. Jefferies set a $85 price target on the same date. Benchmark cut its target from $75 to $65 but kept a buy rating. Cantor Fitzgerald maintains an overweight rating.
Based on 12 analysts, the stock carries a Strong Buy consensus, with nine buy ratings and three holds. The average price target of $64.13 implies roughly 16% upside from Wednesday’s close.
Some commentary has flagged potential headwinds, noting the stock’s run may have moved ahead of fundamentals. Weiss Ratings moved the stock from a “sell (d-)” to a “sell (d+)” earlier this week.
IonQ’s market cap stands at approximately $20.23 billion.
The post IonQ Stock: Revenue Up 755% But Shares Slide — Here’s Why appeared first on CoinCentral.
